Healthcare Services

Peripheral Arterial Disease Market Report 2026: Strategic Insights and Revenue Outlook

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the peripheral arterial disease market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Peripheral Arterial Disease Market?

The peripheral arterial disease market has demonstrated robust expansion in recent years. It is projected to increase from $4.74 billion in 2025 to $5.12 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.1%. Key factors contributing to its historical growth include the high prevalence of peripheral arterial disease, limited awareness of PAD symptoms, reliance on conventional medications, inadequate access to vascular specialists, and fragmented care delivery systems.

The peripheral arterial disease market size is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $7.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. Factors contributing to this growth during the forecast period include advances in minimally invasive endovascular techniques, the increasing acceptance of drug-eluting devices, the expansion of hospitals and specialized clinics dedicated to PAD treatment, heightened patient awareness regarding timely intervention, and the escalating application of combined therapies that encompass lifestyle changes and medications. Key trends expected within this period involve the expanding utilization of AI for early detection and risk evaluation, a greater uptake of digital and cloud-based systems for patient monitoring, an intensifying emphasis on personalized PAD treatments based on genomics, the growing deployment of IoT-enabled devices for tracking after treatment, and the increasing incorporation of smart manufacturing methods in the production of PAD devices.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp

Which Drivers Are Supporting The Rise Of The Peripheral Arterial Disease Market?

The expanding incidence of diabetes is anticipated to boost the peripheral arterial disease market in the future. Diabetes is defined as a long-term metabolic condition marked by elevated blood glucose levels. An increase in diabetes cases consequently raises the need for its treatments. This rise in diabetes significantly contributes to peripheral arterial disease (PAD), as diabetic individuals face an increased likelihood of developing atherosclerosis, the primary cause of PAD, which necessitates intervention. For example, reports from The Office for Health Improvement and Disparities (OHID), a UK-based government agency, indicated in March 2024 that the proportion of people with type 1 diabetes receiving eight care processes grew by 22% between the 15 months ending March 2022 and March 2023, with a 21% increase for type 2 diabetes during the same period. Consequently, the rising prevalence of diabetes is fueling the expansion of the peripheral arterial disease market.

What Leading Segments Are Studied In The Peripheral Arterial Disease Market?

The peripheral arterial disease market covered in this report is segmented –

1) By Treatment Type: Devices, Catheters, Drugs, Other Types

2) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

3) By End User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Devices: Stents, Balloons, Atherectomy Devices

2) By Catheters: Drug-Eluting Catheters, Balloon Catheters, Guidewires

3) By Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators

4) By Other Types: Surgical Interventions, Lifestyle Modification Programs, Endovascular Therapy

Which Innovation Trends Are Advancing Developments Within The Peripheral Arterial Disease Market?

Companies operating in the peripheral arterial disease market are heavily invested in developing sophisticated medical devices, such as the intravascular lithotripsy (IVL) catheter, aimed at boosting treatment efficacy, improving patient outcomes, and decreasing recovery times for individuals affected by vascular conditions. The intravascular lithotripsy (IVL) catheter serves as a medical device for addressing calcified arterial blockages by emitting controlled shockwaves to fragment calcium, thereby aiding in the restoration of blood flow and enhancing vessel flexibility during procedures like angioplasty. For instance, in September 2024, Shockwave Medical, Inc., a U.S.-based medical technology company, introduced the Shockwave E8 peripheral IVL catheter. This device is specifically engineered to treat peripheral arterial disease through targeted intravascular lithotripsy, employing sonic waves to break down calcium deposits in arterial walls. This innovative strategy helps re-establish blood flow while simultaneously minimizing trauma to adjacent tissues. The catheter’s advanced construction also facilitates easier navigation within complex vascular anatomy, rendering it suitable for a broad spectrum of patients.

Which Key Players Are Driving Competition In The Peripheral Arterial Disease Market?

Major companies operating in the peripheral arterial disease market are Johnson and Johnson Limited, Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Which Region Is Projected To Lead The Peripheral Arterial Disease Market During The Forecast Period?

North America was the largest region in the peripheral artery disease market in 2025. The regions covered in the peripheral arterial disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Peripheral Arterial Disease Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12999&type=smp

Browse Through More Reports Similar to the Global Peripheral Arterial Disease Market 2026, By The Business Research Company

Peripheral Neuropathy Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Vascular Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795